About GeneTech
GeneTech is a Healthcare company based in Hyderabad (India) founded in 1998 by Anuradha Udumudi. It operates as a biomedical genetics, prenatal, and avian genetic testing services are provided. It operates on a Professional Services model. The company has 19 employees. GeneTech was last valued at $1.82 million in August 2018. Its chief executive is Anuradha Udumudi. Its Indian entity Ats Genetech Private Limited reported revenue of ₹8.52 Cr. GeneTech offers products and services including Genetic Testing, Prenatal Screening, and Newborn Screening. Its focus areas include Diagnostics and Genetic Testing. Its competitors include Viome, Invitae, Color, Everlywell and Novogene Corporation and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
GeneTech is established as a premier genetics testing laboratory in India, offering a comprehensive range of over 700 tests covering thousands of diseases. Services are provided in areas such as NGS, MicroArray, Molecular, Chromosomal, and Biochemical Genetics. The company is trusted for prenatal and neonatal diagnostics, utilizing cutting-edge technology to ensure reliable results. Operations are conducted across India, with a focus on affordability and specificity in diagnostic solutions for various medical needs.
- Headquarters Hyderabad, India
- Employees 19
- Founders Anuradha Udumudi
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website genetech.co.in
- Social LinkedIn X Facebook Instagram
- Legal Name Ats Genetech Private Limited
- Date of Incorporation 01 Jul, 1998
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹8.52 Cr
FY 2024 · +29% YoY
- Net Profit₹65.9 Lakh
FY 2024 · 8% margin
- EBITDA₹1.83 Cr
FY 2024 · 21% margin
- Latest Funding Round$364.88K (USD), Unspecified
Aug 2018
- InvestorsVenture Finance
& 1 more
- Employee Count19
Associated legal entities of GeneTech
GeneTech operates through Ats Genetech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ats Genetech Private Limited CIN U73100TG1998PTC029694 | Active | 01 Jul 1998 | Hyderabad, Telangana | ₹8.5 Cr | 19 | 2 | View details |
Products & Services of GeneTech
GeneTech offers a comprehensive portfolio of products and services, including Genetic Testing, Prenatal Screening, and Newborn Screening.
Genetic testing services are provided for various diseases.
Prenatal screening tests are offered for fetal defects.
Newborn screening tests are conducted for genetic disorders.
Funding Insights of GeneTech
- Total Rounds 1
- Last Round Unspecified — $364,878
- First Round $364,878
(Aug 2018)
- Investors Count 2
All 1 funding rounds of GeneTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $364,878 | Unspecified | $1.82M | Venture Finance |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2018 | $1.82M | •••••••• |
Last known valuation $1.82M (Aug 2018). 2 investors in total: 1 institutional and 1 angel.
Investors in GeneTech
GeneTech has secured backing from 2 investors, including institutional and angel investors. Prominent investors backing the company include Venture Finance and Srinivasa Rao Alluri.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of banking, finance, and insurance services | – | venturefinance.co.in | Delhi, India | |
SR Srinivasa Rao Alluri | - | – | unknown_6f3dd1212b494a718 | - |
Investor details for GeneTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ats Genetech Private Limited (GeneTech)
Ats Genetech Private Limited is the primary company behind GeneTech. The board of Ats Genetech Private Limited currently have 2 directors; the longest-serving is Veera Babu Srinivas Udumudi, appointed in 1998. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Veera Babu Srinivas Udumudi DIN 00789221 | Director | 01 Jul 1998 | 28 yrs 3 mo | Ats Genetech Private Limited |
| Anuradha Udumudi DIN 01906650 | Director | 01 Jul 1998 | 28 yrs 3 mo | Ats Genetech Private Limited |
People of GeneTech
1 people are tracked at GeneTech (1 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for GeneTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of GeneTech
Figures of Ats Genetech Private Limited, the primary company behind GeneTech, for FY 2024. Revenue was ₹8.52 Cr (+29% year on year). Net profit was ₹65.9 Lakh (8% margin). EBITDA was ₹1.83 Cr (21% margin). Revenue has grown at a compounded annual rate of +35% over three years and +20% over five years.
- ₹8.52 CrRevenue · FY 2024 · +29% YoY
- ₹65.9 LakhNet profit · 8% margin
- ₹1.83 CrEBITDA · 21% margin
- ₹15 LakhPaid-up capital
- 19Employees (provident fund records)
- +35%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ats Genetech Private Limited are on its company page.
Detailed financial statements for GeneTech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of GeneTech
3 dated milestones of GeneTech across 20 years, from founding to its latest funding, stage changes and deals.
- Founded GeneTech is founded.
- Funding First funding round of $365K.
- Milestone Reaches Minicorn status.
Competitors of GeneTech
GeneTech has 10 listed competitors in our database, 9 of them funded. They include Viome, Invitae, Color, Everlywell and Novogene Corporation, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of GeneTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GeneTech
The website of GeneTech (genetech.co.in) receives about 2.4K visits a month and ranks #9,938,815 among all websites worldwide, #7,806 in Biotechnology and Pharmaceuticals.
- Monthly visits2.4K
▲ 39.1% vs previous month
- Global rank#9,938,815
among all websites
- Category rank#7,806
Health · Biotechnology and Pharmaceuticals
- Bounce rate47%
- Pages per visit1.3
- Average visit11 sec
- DevicesDesktop 47% · Mobile 53%
Websites whose visitors overlap most with GeneTech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 4basecare.com | 100% | 5.7K | #3,663,212 | View details | |
genetrack.in | genetrack.in | 95% | – | #1,807,695 | – |
| sbpsoftware.com | 69% | – | – | View details | |
genetics.edu.au | genetics.edu.au | 69% | – | #888,034 | – |
centreforability.bc.ca | centreforability.bc.ca | 68% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for GeneTech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as GeneTech (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GeneTech
GeneTech was founded in 1998 and raised its 1st funding round 20 years after it was founded.
GeneTech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Anuradha Udumudi is the current CEO of GeneTech. They have also founded this company.
GeneTech has 19 employees.
The primary company behind GeneTech, Ats Genetech Private Limited, reported revenue of ₹8.52 Cr for FY 2024, up 29% year on year.
GeneTech is established as a premier genetics testing laboratory in India, offering a comprehensive range of over 700 tests covering thousands of diseases. Services are provided in areas such as NGS, MicroArray, Molecular, Chromosomal, and Biochemical Genetics. The company is trusted for prenatal and neonatal diagnostics, utilizing cutting-edge technology to ensure reliable results. Operations are conducted across India, with a focus on affordability and specificity in diagnostic solutions for various medical needs.
GeneTech's top competitors include Viome, Novogene Corporation and Variant Bio.
GeneTech offers Genetic Testing, Prenatal Screening, and Newborn Screening.
GeneTech has 2 investors. Key investors include Venture Finance, and Srinivasa Rao Alluri.
The valuation of GeneTech is $1.82M as of Aug 2018.
GeneTech operates through Ats Genetech Private Limited.
The legal entities of GeneTech currently have 2 directors, including Veera Babu Srinivas Udumudi, Anuradha Udumudi.